Biomarkers of Inflammation and Coagulation Are Associated with Mortality and Hepatitis Flares in Persons Coinfected with HIV and Hepatitis Viruses

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2013 Jan 22

PMID 23335804

Citations 26

Authors

Bruno Bezerril Andrade

Katherine Huppler Hullsiek

David R Boulware

Adam Rupert

Martyn A French

Kiat Ruxrungtham

Marisa Luisa Montes

Huw Price

Pablo Barreiro

Jennifer Audsley

Alan Sher

Sharon R Lewin

Irini Sereti

Affiliations

Soon will be listed here.

Abstract

Background: Hepatitis C virus (HCV) and/or hepatitis B virus (HBV) coinfection with human immunodeficiency virus (HIV) has a greater risk of mortality than either HCV or HBV infection alone and is frequently associated with hepatitis flares after antiretroviral therapy (ART) initiation.

Methods: We performed a retrospective cohort study of 287 HIV-positive persons coinfected with HBV and/or HCV (70 had HBV coinfection only, 207 had HCV coninfection only, and 10 had HBV and HCV coinfections) who had pre-ART plasma samples evaluated for biomarkers associated with death (within 4 years) and/or hepatitis flare (within 4 months) after ART initiation. A predictive biomarker risk score was calculated.

Results: Forty-eight deaths and 50 hepatitis flares occurred. Nonsurvivors were older, had more prior AIDS-defining events, and had higher pre-ART triglycerides and aspartate transaminase levels. Detectable hyaluronic acid and higher d-dimer, interleukin 6, interleukin 8, and soluble CD14 levels were associated with death in univariate models and with a composite biomarker risk score. The risk of hepatitis flares was higher with HBV coinfection only (24.3%) and with HBV and HCV coinfection (50%) than with HCV coinfection only (13.5%). Higher levels of alanine transaminase and interleukin 10 were also associated with hepatitis flares.

Conclusions: Among HIV-positive patients coinfected with HBV and/or HCV who are initiating ART, biomarkers of inflammation and coagulation are associated with an increased risk of death, whereas HBV coinfection and higher pre-ART interleukin 10 levels are associated with hepatitis flares.

Citing Articles

Proinflammatory Biomarkers and Clinical Factors Associated with Long-Term Mortality in People with HIV.

Lembas A, Zaleski A, Mikula T, Kozlowska J, Wiercinska-Drapalo A Viruses. 2025; 17(2).

PMID: 40006998 PMC: 11860511. DOI: 10.3390/v17020243.

The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial Interconnection.

Mazzuti L, Turriziani O, Mezzaroma I Biomedicines. 2023; 11(1).

PMID: 36672667 PMC: 9856151. DOI: 10.3390/biomedicines11010159.

Immunologic biomarkers, morbidity and mortality among HIV patients hospitalised in a Tertiary Care Hospital in the Brazilian Amazon.

Gama W, Frank C, Almeida T, Dos Santos D, Chaves Y, da Silva D BMC Infect Dis. 2021; 21(1):876.

PMID: 34445956 PMC: 8394190. DOI: 10.1186/s12879-021-06566-x.

Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV.

Vinhaes C, Araujo-Pereira M, Tiburcio R, Cubillos-Angulo J, Demitto F, Akrami K Life (Basel). 2021; 11(1).

PMID: 33477581 PMC: 7831327. DOI: 10.3390/life11010065.

An Inflammatory Composite Score Predicts Mycobacterial Immune Reconstitution Inflammatory Syndrome in People with Advanced HIV: A Prospective International Cohort Study.

Vinhaes C, Sheikh V, Oliveira-de-Souza D, Wang J, Rupert A, Roby G J Infect Dis. 2020; 223(7):1275-1283.

PMID: 32761193 PMC: 8030712. DOI: 10.1093/infdis/jiaa484.

References

Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, dArminio Monforte A . Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003; 362(9377):22-9. DOI: 10.1016/s0140-6736(03)13802-0. View

Kuller L, Tracy R, Belloso W, De Wit S, Drummond F, Lane H . Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008; 5(10):e203. PMC: 2570418. DOI: 10.1371/journal.pmed.0050203. View

Sandler N, Wand H, Roque A, Law M, Nason M, Nixon D . Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011; 203(6):780-90. PMC: 3071127. DOI: 10.1093/infdis/jiq118. View

Kovari H, Ledergerber B, Battegay M, Rauch A, Hirschel B, Foguena A . Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection. Clin Infect Dis. 2010; 50(4):502-11. DOI: 10.1086/649922. View

El-Sadr W, Lundgren J, Neaton J, Gordin F, Abrams D, Arduino R . CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006; 355(22):2283-96. DOI: 10.1056/NEJMoa062360. View

Murphy E, Collier A, Kalish L, Assmann S, Para M, Flanigan T . Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001; 135(1):17-26. DOI: 10.7326/0003-4819-135-1-200107030-00005. View

Puoti M, Torti C, Bruno R, Filice G, Carosi G . Natural history of chronic hepatitis B in co-infected patients. J Hepatol. 2005; 44(1 Suppl):S65-70. DOI: 10.1016/j.jhep.2005.11.015. View

Malavaud B, Dinh B, Bonnet E, Izopet J, Payen J, Marchou B . Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection. Antivir Ther. 2000; 5(1):3-5. View

Sandler N, Koh C, Roque A, Eccleston J, Siegel R, Demino M . Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology. 2011; 141(4):1220-30, 1230.e1-3. PMC: 3186837. DOI: 10.1053/j.gastro.2011.06.063. View

10.

den Brinker M, Wit F, Jurriaans S, Weel J, van Leeuwen R, Pakker N . Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS. 2001; 14(18):2895-902. DOI: 10.1097/00002030-200012220-00011. View

11.

Hearps A, Maisa A, Cheng W, Angelovich T, Lichtfuss G, Palmer C . HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012; 26(7):843-53. DOI: 10.1097/QAD.0b013e328351f756. View

12.

Ofotokun I, Smithson S, Lu C, Easley K, Lennox J . Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy. Am J Med Sci. 2007; 334(5):334-41. PMC: 3075308. DOI: 10.1097/MAJ.0b013e31811ec780. View

13.

Shin H, Park B, Kim L, Jung J, Kim J, Yoon J . Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet. 2003; 12(8):901-6. DOI: 10.1093/hmg/ddg104. View

14.

Palella Jr F, Baker R, Moorman A, Chmiel J, Wood K, Brooks J . Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006; 43(1):27-34. DOI: 10.1097/01.qai.0000233310.90484.16. View

15.

Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein M . Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis. 2008; 47(11):1468-75. DOI: 10.1086/593102. View

16.

MacArthur R, Novak R, Peng G, Chen L, Xiang Y, Hullsiek K . A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy.... Lancet. 2006; 368(9553):2125-35. DOI: 10.1016/S0140-6736(06)69861-9. View

17.

Li J, Wu W, Peng G, Chen F, Bai M, Zheng M . HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol. 2010; 88(8):834-41. DOI: 10.1038/icb.2010.63. View

18.

Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M . The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology. 2001; 34(6):1193-9. DOI: 10.1053/jhep.2001.29201. View

19.

Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H . Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000; 356(9244):1800-5. DOI: 10.1016/s0140-6736(00)03232-3. View

20.

Boulware D, Bonham S, Meya D, Wiesner D, Park G, Kambugu A . Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J Infect Dis. 2010; 202(6):962-70. PMC: 2924457. DOI: 10.1086/655785. View